Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013;12(4):157-65.

Pharmacokinetic and pharmacodynamic properties of the new AEDs: A review article

Affiliations
Review

Pharmacokinetic and pharmacodynamic properties of the new AEDs: A review article

Majid Ghaffarpour et al. Iran J Neurol. 2013.

Abstract

The new-AEDs, whose developments were motivated following the discovery of the valproate and its marketing in the U.S in 1978, have presented more therapeutic options. There are approximately twenty four FDA-approved antiepileptic drugs for use in patients with epilepsy, five of which were identified and have come on to the market between 2009 and 2012. The new-AEDs are of interest, not due to their efficacy, but rather owing to better tolerance, favorable pharmacokinetic profile, fewer interactions, and in some instances, lesser protein binding. No standard AED or those in developing have all properties of an ideal antiepileptic drug, thus to achieve desirable outcome, physicians should be aware of pharmacokinetics (PKs) and pharmacodynamics (PDs) of drugs. This review describes briefly the major features of the new AEDs.

Keywords: Antiepileptic Drugs; Epilepsy; New Generation; Pharmacokinetics; Seizure.

PubMed Disclaimer

References

    1. Marson AG, Chadwick DW. New drug treatments for epilepsy. J Neurol Neurosurg Psychiatry. 2001;70(2):143–7. - PMC - PubMed
    1. Dichter MA, Brodie MJ. New antiepileptic drugs. N Engl J Med. 1996;334(24):1583–90. - PubMed
    1. Curry WJ, Kulling DL. Newer antiepileptic drugs: gabapentin, lamotrigine, felbamate, topiramate and fosphenytoin. Am Fam Physician. 1998;57(3):513–20. - PubMed
    1. Rosner H, Rubin L, Kestenbaum A. Gabapentin adjunctive therapy in neuropathic pain states. Clin J Pain. 1996;12(1):56–8. - PubMed
    1. Perucca E. The clinical pharmacokinetics of the new antiepileptic drugs. Epilepsia. 1999;40(Suppl 9):S7–13. - PubMed

LinkOut - more resources